Clinical Trials Directory

Trials / Unknown

UnknownNCT03086902

Comparision of PVC Ablation Techniques

Cryo Ablation vs. Radiofrequency Catheter Ablation for Ventricular Premature Contractions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Several reports have shown the utility of PVC ablation with cryo catheters. The aim of this study is to compare the outcomes and safety of Cryo vs. RF for PVCs.

Detailed description

Background: Radiofrequency (RF) catheter ablation (CA) is an effective therapeutic strategy in eliminating refractory idiopathic ventricular outflow tract (OT) ventricular arrhythmias (VA). However, early and late recurrences occur commonly. RFCA has also been reported to be associated with collateral damage and pain. The use of Cryo ablation as a safer alternative energy source been previously described. In several reports Cryo was reported to successfully treat VA originating from the OT in the absence of ablation related pain and collateral damage to adjacent structures such as the coronaries. When comparing outcomes and complications of catheter ablation of VA from the papillary muscles of the left ventricle with either Cryo or RF, Cryo was found to be associated with significantly higher success rates and lower recurrence rates than RFCA. Aim: To compare the outcomes and safety of Cryo vs. RF for PVCs. Methods: Patients with PVC VA will be randomized in a 1:1 fashion to RFCA or Cryo ablation. All procedures will be done using a 3-dimensional mapping system (EnSite™ NavX™ system, St. Jude Medical). Ablation will be performed at sites with earliest activation or at least pacemap exhibiting QRS morphology match of \>11/12. Endpoint of procedure will be elimination and non inducibility of the clinical VA. All patients will undergo continuous monitoring for at least 12 hours post procedure and 12 lead Holter and exercise testing 1 month post procedure. Successful ablation will be defined as absence of clinical VA or \> 50% reduction in arrhythmia burden on Holter in the absence of anti-arrhythmic medications.

Conditions

Interventions

TypeNameDescription
DEVICERadiofrequency Ablation CatheterAblation of PVC with RF energy
DEVICECryo Ablation catheterAblation pf PVC with Cryo enerygy

Timeline

Start date
2018-12-01
Primary completion
2020-07-01
Completion
2021-07-01
First posted
2017-03-22
Last updated
2018-06-06

Regulatory

Source: ClinicalTrials.gov record NCT03086902. Inclusion in this directory is not an endorsement.